COA vs SDS for Research Peptides: What Each Document Does

A Certificate of Analysis (COA) and a Safety Data Sheet (SDS) answer different questions. The COA documents what is in a specific batch: identity, purity, and the test results behind them. The SDS, formerly called the MSDS, documents hazards and handling for the product as a chemical, and it is not tied to the quality of any single lot. A research laboratory needs both on file, and neither can substitute for the other.

For Research Use Only. Not for human or veterinary use.

TL;DR

• A COA is batch-specific analytical evidence (identity, purity, content). An SDS is a standardized hazard and handling document in a fixed 16-section format.
• MSDS is the old name. OSHA’s Hazard Communication Standard now uses “Safety Data Sheet,” and the format is standardized.
• An SDS cannot tell you whether a lot meets its specification, and a COA cannot tell your safety officer how to store, handle, or dispose of the material.
• Verify the COA’s lab, lot number, methods, and raw data. Treat a missing or generic COA as a procurement red flag.
• File both against the lot number in your lab records so every experiment traces back to documented material.

Table of Contents

• Why the two documents get confused
• What a COA contains
• What an SDS contains
• Do research peptides always need an SDS?
• COA vs SDS: side-by-side comparison
• Using both documents together
• When the COA is missing or thin
• Research-use-only labeling and what it means for documents
• Our perspective
• Sourcing documented research materials
• FAQ
• Sources

Why the two documents get confused

Both arrive with a shipment, both carry the product name, and both are often requested together in a vendor questionnaire. Search results reflect the confusion: readers type “MSDS” for a document that has had a different name for over a decade, and they expect one file to cover quality and safety at once.

The documents differ in purpose, author, regulatory footing, and the decisions they support. The COA supports scientific decisions: whether this lot is fit for the assay you designed. The SDS supports workplace safety decisions: how to store, handle, and dispose of the material, and what to do in an emergency. USP General Chapter <1083> frames supplier qualification as a risk-based process aimed at confirming materials are fit for their intended use, which is the quality half of the picture. The safety half is governed separately.

What a COA contains

A COA is issued for one batch. Under the language of FDA’s Q7A guidance on good manufacturing practice, it records the tests performed, the acceptance limits, and the actual results obtained. Q7A is written for pharmaceutical ingredient manufacturers, not research suppliers, but the logic of a batch-level record translates directly to research procurement.

For a synthetic peptide, a complete COA typically shows:

• Product name and sequence or identifier, so the document matches what you ordered.
• Lot or batch number, which ties the document to the vial in your freezer.
• Issuing laboratory, including whether testing was performed in-house or by an independent third party.
• Identity by mass spectrometry, with the observed mass shown beside the theoretical mass for the sequence.
• Purity by HPLC, ideally with the chromatogram attached, not just a percentage.
• Content or net peptide content, where measured, since total mass in a vial includes counterions and water.
• Appearance, format, and test date.

The numbers matter less than whether you can trace them. A purity figure with no chromatogram, no method, and no lot number is an assertion, not evidence. Our guide to examples of quality peptide lab reports walks through what a well-documented report looks like, and a separate reference on batch-specific quality information on a peptide COA covers the lot-level details researchers should check.

Who verifies the COA

FDA’s Q7A guidance notes that a manufacturer may rely on a supplier’s COA to reduce its own testing only when it has qualified the supplier and periodically confirms the COA’s reliability with complete analyses. The guidance also stresses knowing which laboratory actually performed the analysis, which matters most when the document comes from a repacker or broker rather than the original manufacturer. Research labs are not bound by Q7A, but the discipline is sound: read the COA as a claim, then decide how much independent confirmation the experiment warrants.

What an SDS contains

The SDS is a regulatory document. OSHA’s guide to Safety Data Sheets explains that the Hazard Communication Standard (29 CFR 1910.1200) requires chemical manufacturers, distributors, and importers to provide an SDS for each hazardous chemical. The standard uses a consistent 16-section format, and Appendix D to the standard specifies the information required under each section heading.

The sections cover, in order, identification, hazard identification, composition, first-aid measures, fire-fighting measures, accidental release measures, handling and storage, exposure controls and personal protection, physical and chemical properties, stability and reactivity, toxicological information, ecological information, disposal considerations, transport information, regulatory information, and other information. Appendix D also notes that if no relevant information exists for a subheading, the SDS must say so rather than leave it blank.

Three features distinguish the SDS from a COA:

1. It describes the product, not the lot. The same SDS usually applies to every batch of that product.
2. It is not an analytical record. Section 9 lists physical and chemical properties, but it does not report the purity of what you received.
3. It is addressed to the people handling the material. Its audience is the researcher, the safety officer, and emergency responders.

MSDS versus SDS

MSDS is the pre-2012 name. OSHA’s own publication states that SDSs were formerly known as MSDSs, and the revised Hazard Communication Standard aligned the format with the Globally Harmonized System. If a vendor still supplies a document titled “MSDS,” check the revision date and confirm it follows the 16-section layout. An outdated document is a documentation gap your safety office will want to close.

Do research peptides always need an SDS?

Not always as a matter of regulation, but usually in practice. OSHA’s requirement applies to hazardous chemicals. In a letter of interpretation on the purpose of safety data sheets, OSHA addresses how the requirement works for materials and why producers sometimes supply documents beyond what is strictly required. A supplier that provides an SDS for a material that may not be classified as hazardous is generally practicing careful chemical management, and most institutional safety programs expect one regardless.

For academic and institutional laboratories, the OSHA Laboratory standard (29 CFR 1910.1450) points to safety data sheets received from the chemical supplier as reference material that employees must be able to locate. In practical terms, your chemical hygiene plan probably assumes an SDS is on file for each substance in the lab. Confirm the specifics with your institution’s environmental health and safety office, since local policy is often stricter than the federal baseline.

Our risk assessment guide for research peptide handling covers how the SDS feeds into a lab’s written assessment.

COA vs SDS: side-by-side comparison

Using both documents together

The two documents fail in opposite ways. With a COA and no SDS, the batch is verified but your handling, storage, and disposal procedures lack a documented basis. With an SDS and no COA, the safety side is covered but you have no evidence of what is actually in the vial. USP <1083> treats the COA as a primary indicator of a supplier’s quality system, and the SDS is a compliance necessity on the safety side. Confusing their roles opens gaps in both.

A practical intake workflow

1. Match the paperwork to the package. Compare the lot number on the vial label with the COA before opening anything.
2. Check the COA for completeness. Look for the identity method, the purity method, the observed versus theoretical mass, and the laboratory name.
3. Review the chromatogram and spectrum, not only the summary. A single percentage hides co-eluting impurities and truncated sequences.
4. File the SDS in your chemical inventory system. Record the revision date and give your safety office a copy.
5. Link both to the lot in your lab notebook or LIMS. Every experiment should be able to cite the lot, the COA, and the storage history.
6. Decide whether to re-verify. For critical or long-running studies, an in-house identity or content check is reasonable. Our guide to batch testing workflow outlines how to structure this.

This fits into the wider documentation expectations described in our peptide documentation standards for academic labs.

When the COA is missing or thin

A missing batch-specific COA limits what you can claim about your own results, because you cannot establish baseline experimental conditions with confidence. If you already hold the material, there are fallbacks. The consensus recommendations on peptide generation, quantification, storage and handling describe UV absorbance as one option when extinction coefficients are known, and amino acid analysis as the more accurate approach to quantification.

The same reference covers storage points that belong in your handling records, not on a COA: peptides can degrade through oxidation, particularly at cysteine, methionine, and tryptophan residues, and are commonly stored sealed, protected from light, and at low temperature. Check the SDS and the supplier’s storage statement for the specific product, then document what you actually did.

Solubility problems are a separate matter from documentation. Solubility is sequence-dependent, so no universal approach exists. The same PMC reference recommends testing a small aliquot before committing the whole batch, and notes that a cloudy solution does not automatically indicate a failed synthesis. Neither the COA nor the SDS replaces that bench-level judgment, though a COA with the sequence and net peptide content gives you the starting information for it.

Research-use-only labeling and what it means for documents

RUO labeling is a labeling category with consequences, not a shortcut around documentation. The FDA’s page on bioresearch monitoring of in vitro diagnostic devices states that products shipped solely for research must carry the “For Research Use Only, Not for use in diagnostic procedures” statement, and that using an RUO-labeled product in clinical investigations can render it misbranded. That page concerns diagnostic devices, so apply it to other product categories with caution and ask your compliance office how it maps to your work. We discuss the distinctions in RUO vs IVD guidance for labs and in our overview of research peptide rules for U.S. labs.

RUO status does not exempt a supplier from providing hazard information, and it does not make a COA optional for a serious buyer. It simply defines the intended setting: analytical and laboratory research.

Our perspective

We see the COA and the SDS as two halves of one documentation package, and we think a supplier should be judged on both. Our position is built on batch-level documentation, independent third-party laboratory testing, and traceability: each compound should reach a laboratory with a COA that corresponds to its lot, and our published position is a purity standard of at least 99%.

The most common problem we see in the field is not a missing document but an unreadable one: a purity number without a chromatogram, a lot number that does not match the vial, or an SDS filed once and never revisited. A researcher should be able to place the COA, the SDS, and the vial on a bench and see that all three refer to the same material. Where they cannot, the correct response is to ask the supplier questions before the material enters an experiment.

We publish our Certificates of Analysis and encourage researchers to read them against the checklist above. For evaluating any supplier, our vendor evaluation criteria and supplier audit checklist set out what we would ask in your position.

— Vertex Labs Editorial Team

Sourcing documented research materials

Vertex Labs supplies research-use-only peptides, blends, compounds, and sterile solutions to laboratories across the United States and Puerto Rico, each with batch-specific COAs from independent third-party testing. Institutions can also ask about custom peptide sequences and bulk procurement. Browse the research catalog or visit the Vertex Labs homepage to review product lines and documentation.

FAQ

Is an MSDS the same as a COA?

No. An MSDS, now called an SDS, communicates hazards, handling, storage, and emergency information for a chemical product. A COA reports test results for a specific batch, such as identity and purity. They answer different questions, and a lab needs both.

Do I still need to ask for an MSDS?

Ask for an SDS. OSHA replaced the MSDS terminology, and the current standard requires a 16-section format for hazardous chemicals. If a supplier sends a document titled MSDS, check its revision date and section structure, then confirm what your institution’s safety office requires.

Can an SDS tell me the purity of a peptide?

Not reliably. The SDS describes the product generally and may list composition ranges, but it does not report results for your lot. Purity and identity belong on the COA, supported by HPLC and mass spectrometry data.

What should I do if a COA does not match my vial?

Quarantine the material and do not use it in experiments. Compare the lot number, product name, and test date, then contact the supplier for the correct document or raw data. Record the discrepancy and its resolution in your lab files.

Sources

• OSHA, Hazard Communication Standard: Safety Data Sheets
• OSHA, Hazard Communication Appendix D
• OSHA, letter of interpretation on the purpose of safety data sheets
• OSHA, 29 CFR 1910.1450, Occupational exposure to hazardous chemicals in laboratories
• FDA, Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients
• USP General Chapter <1083>
• FDA, Bioresearch Monitoring Inspections of In Vitro Diagnostics Devices
• Recommendations for the generation, quantification, storage and handling of peptides used for mass spectrometry-based assays (PMC)

Recommended

• Peptide Documentation Standards for Academic Labs
• Research-Grade Peptide Formats Comparison for Researchers
• Testing Standards & COA Verification
• Certificates of Analysis (CoAs)